View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Midland States Bancorp, Inc. to Announce Fourth Quarter 2025 Financial...

Midland States Bancorp, Inc. to Announce Fourth Quarter 2025 Financial Results on Thursday, January 22 EFFINGHAM, Ill., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) announced today that it will issue its fourth quarter 2025 financial results after market close on Thursday, January 22, 2026. Along with the press release announcing the financial results, the Company will publish an investor presentation that will be available on the  page of its investor relations website. About Midland States Bancorp, Inc. Midland States Bancorp, Inc. is a community-based...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of W&T Offshore, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 December 2025 in which we reassessed the appropriateness of the ratings in the contex...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 6, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Midland States Bancorp Announces Sale of Substantially All of Its Equi...

Midland States Bancorp Announces Sale of Substantially All of Its Equipment Finance Portfolio to North Mill Equipment Finance EFFINGHAM, Ill., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) today announced that its wholly owned subsidiary, Midland States Bank (“the Company”), has sold substantially all of its equipment finance portfolio to an affiliate of North Mill Equipment Finance LLC (“NMEF”). The transaction closed on November 28, 2025. NMEF acquired the portfolio for $502 million in cash, subject to adjustment. As of October 31, 2025, the equipment fi...

 PRESS RELEASE

Midland States Bancorp, Inc. Announces Planned Retirement of Jeffrey S...

Midland States Bancorp, Inc. Announces Planned Retirement of Jeffrey S. Mefford EFFINGHAM, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) (the “Company”), announced today Jeffrey S. Mefford will retire from his role as President of its wholly-owned subsidiary Midland States Bank (the “Bank”) and as Executive Vice President of the Company on June 30, 2026. Mefford has served as President of the Bank for seven years and has been employed with the Bank for 22 years. “Jeff has played a key role in our growth over many years, particularly in strengthening ...

 PRESS RELEASE

Midland States Bancorp, Inc. Announces Authorization of New $25 Millio...

Midland States Bancorp, Inc. Announces Authorization of New $25 Million Stock Repurchase Program EFFINGHAM, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors has approved a new stock repurchase program that authorizes the Company to repurchase up to $25 million of its common stock. The new stock repurchase program will become effective on November 3, 2025 and expires on November 2, 2026. The Company’s most recent stock repurchase program expired on December 31, 2024. Jeffrey G. Ludwig, President and Chief Execu...

 PRESS RELEASE

Midland States Bancorp, Inc. Announces Common Stock and Preferred Stoc...

Midland States Bancorp, Inc. Announces Common Stock and Preferred Stock Dividends EFFINGHAM, Ill., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors declared a quarterly cash dividend of $0.32 per share of its common stock. The dividend is payable on November 21, 2025 to all shareholders of record as of the close of business on November 14, 2025. The Board of Directors also declared a cash dividend of $0.4844 per depository share on its 7.75% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A. The di...

 PRESS RELEASE

Midland States Bancorp, Inc. Announces 2025 Third Quarter Results

Midland States Bancorp, Inc. Announces 2025 Third Quarter Results EFFINGHAM, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) (the “Company”) today reported net income available to common shareholders of $5.3 million, or $0.24 per diluted share, for the third quarter of 2025, compared to net income available to common shareholders of $9.8 million, or $0.44 per diluted share, for the second quarter of 2025. This also compares to net income of $18.2 million, or $0.83 per diluted share, for the third quarter of 2024. 2025 Third Quarter Results Net incom...

 PRESS RELEASE

Midland States Bancorp, Inc. to Announce Third Quarter 2025 Financial ...

Midland States Bancorp, Inc. to Announce Third Quarter 2025 Financial Results on Thursday, October 30 EFFINGHAM, Ill., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its third quarter 2025 financial results after market close on Thursday, October 30, 2025. Along with the press release announcing the financial results, the Company will publish an investor presentation that will be available on the  page of its investor relations website. About Midland States Bancorp, Inc. Midland States Bancorp, Inc. is a community-based f...

 PRESS RELEASE

89bio, Inc. Announces Agreement to be Acquired by Roche

89bio, Inc. Announces Agreement to be Acquired by Roche – 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash; transaction represents total equity value of up to approximately $3.5 billion – – Transaction reflects pegozafermin’s potential best-in-disease profile for the treatment of moderate to severe metabolic dysfunction-associated steatohepatitis (MASH) – – 89bio to join the Roche Group as part of Roche’s Pharmaceutical...

 PRESS RELEASE

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 64,750 shares of the Company’s common stock to three new employees (the “Inducement ...

 PRESS RELEASE

89bio to Participate in Upcoming Investor Conferences

89bio to Participate in Upcoming Investor Conferences SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s management will participate in the following investor conferences during the month of September: Citi’s 2025 Biopharma Back to School ConferenceFormat:Fireside ChatDate:Wednesday, September 3, 2025Time:11:15 AM EDT  Cantor Global Healthcare Conference 2025...

 PRESS RELEASE

Midland States Bancorp, Inc. receives expected notification of deficie...

Midland States Bancorp, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of Quarterly Report on Form 10-Q EFFINGHAM, Ill., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) (the “Company”) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 19, 2025 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to t...

 PRESS RELEASE

89bio Reports Second Quarter 2025 Financial Results and Corporate Upda...

89bio Reports Second Quarter 2025 Financial Results and Corporate Updates – ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 topline histology data expected in 1H 2027 and in 2028, respectively; each trial designed to support accelerated approval to treat patients with metabolic dysfunction-associated steatohepatitis (MASH) – – ENTRUST Phase 3 topline data in severe hypertriglyceridemia (SHTG) expected in 1Q 2026 – – Cash, cash equivalents, and marketable securities totaled $561.2 million as of June 30, 2025 – SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq...

 PRESS RELEASE

Midland States Bancorp, Inc. Increases Common Stock Cash Dividend to ...

Midland States Bancorp, Inc. Increases Common Stock Cash Dividend to $0.32 Per Share and Declares Preferred Stock Dividend EFFINGHAM, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that its Board of Directors declared a quarterly cash dividend of $0.32 per share of its common stock, an increase of 3.2% from the previous quarterly cash dividend of $0.31 per share. The dividend is payable on August 22, 2025 to all shareholders of record as of the close of business on August 15, 2025. The Board of Directors also declared a cash dividend ...

 PRESS RELEASE

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 267,000 shares of the Company’s common stock to three new employees (the “Inducement ...

 PRESS RELEASE

Midland States Bancorp, Inc. Announces 2025 Second Quarter Results

Midland States Bancorp, Inc. Announces 2025 Second Quarter Results EFFINGHAM, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) (the “Company”) today reported net income available to common shareholders of $9.8 million, or $0.44 per diluted share, for the second quarter of 2025, compared to net income available to common shareholders of $23.5 million, or $1.06 per diluted share, for the second quarter of 2024. This also compares to a net loss of $143.2 million, or $6.58 per diluted share, for the first quarter of 2025, which included impairment of goodwi...

 PRESS RELEASE

Midland States Bancorp, Inc. to Announce Second Quarter 2025 Financial...

Midland States Bancorp, Inc. to Announce Second Quarter 2025 Financial Results on Thursday, July 24 EFFINGHAM, Ill., July 10, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its second quarter 2025 financial results after market close on Thursday, July 24, 2025. Along with the press release announcing the financial results, the Company will publish an investor presentation that will be available on the  page of its investor relations website. About Midland States Bancorp, Inc. Midland States Bancorp, Inc. is a community-based finan...

 PRESS RELEASE

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 32,350 shares of the Company’s common stock to two new employees (the “Inducement Gra...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch